N. Davoust et al., VITAMIN-D-RECEPTOR STABLE TRANSFECTION RESTORES THE SUSCEPTIBILITY TO1,25-DIHYDROXYVITAMIN D-3 CYTOTOXICITY IN A RAT GLIOMA RESISTANT CLONE, Journal of neuroscience research, 52(2), 1998, pp. 210-219
Recently, 1,25-dihydroxyvitamin D-3 (1,25-D-3) and less hypercalcemic
analogs were shown to exert a delayed cytotoxic effect on rat C6 gliom
a cells. 1,25-D-3 induces in these cells a programmed cell death, acco
mpanied by the induction of c-myc, p53 and gadd 45 genes. The involvem
ent of the intracellular vitamin D receptor (VDR) remained to be deter
mined. In this lethal process, we have investigated its role in a subc
lone of C6 cells, which was isolated on the basis of its resistance to
1,25-D3, and in which VDR expression was not detected either at the m
RNA or protein levels. The stable transfection of a rat VDR cDNA into
this clone restored its susceptibility to the cytotoxic effects of 1,2
5-D-3, This phenomenon was accompanied by a dramatic upregulation of c
-myc mRNA expression, as already described in a C6-sensitive clone. Th
ese results provide the first evidence that VDR expression, if not suf
ficient, is necessary to mediate 1,25-D-3 cytotoxic effect in C6 gliom
a cells, Since VDR mRNA expression has been already reported in human
brain tumors, our data imply that the identification of VDR expression
could become a prerequisite in any strategy of glioma treatment with
vitamin D analogs. (C) 1998 Wiley-Liss, Inc.